Elai Davicioni
Elai Davicioni
Decipher Biosciences
decipherbio.com üzerinde doğrulanmış e-posta adresine sahip
Alıntı yapanlar
Alıntı yapanlar
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao, L Patel, IA Vergara, ...
Nature genetics 45 (11), 1392, 2013
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy
N Erho, A Crisan, IA Vergara, AP Mitra, M Ghadessi, C Buerki, ...
PloS one 8 (6), e66855, 2013
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
D Chakravarty, A Sboner, SS Nair, E Giannopoulou, R Li, S Hennig, ...
Nature communications 5 (1), 1-16, 2014
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ...
European urology 72 (4), 544-554, 2017
Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition
V Evdokimova, C Tognon, T Ng, P Ruzanov, N Melnyk, D Fink, A Sorokin, ...
Cancer cell 15 (5), 402-415, 2009
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population
RJ Karnes, EJ Bergstralh, E Davicioni, M Ghadessi, C Buerki, AP Mitra, ...
The Journal of urology 190 (6), 2047-2053, 2013
Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas
E Davicioni, FG Finckenstein, V Shahbazian, JD Buckley, TJ Triche, ...
Cancer research 66 (14), 6936-6946, 2006
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
Molecular classification of rhabdomyosarcoma—genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group
E Davicioni, MJ Anderson, FG Finckenstein, JC Lynch, SJ Qualman, ...
The American journal of pathology 174 (2), 550-564, 2009
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
JR Prensner, S Zhao, N Erho, M Schipper, MK Iyer, SM Dhanasekaran, ...
The lancet oncology 15 (13), 1469-1480, 2014
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
RB Den, K Yousefi, EJ Trabulsi, F Abdollah, V Choeurng, FY Feng, ...
Journal of Clinical Oncology 33 (8), 944, 2015
Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate-and high-risk men
AE Ross, MH Johnson, K Yousefi, E Davicioni, GJ Netto, L Marchionni, ...
European urology 69 (1), 157-165, 2016
Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort
MR Cooperberg, E Davicioni, A Crisan, RB Jenkins, M Ghadessi, ...
European urology 67 (2), 326-333, 2015
The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis
Y Yu, E Davicioni, TJ Triche, G Merlino
Cancer research 66 (4), 1982-1989, 2006
A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy …
EA Klein, K Yousefi, Z Haddad, V Choeurng, C Buerki, AJ Stephenson, ...
European urology 67 (4), 778-786, 2015
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy
SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ...
JAMA oncology 3 (12), 1663-1672, 2017
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
RB Den, FY Feng, TN Showalter, MV Mishra, EJ Trabulsi, CD Lallas, ...
International Journal of Radiation Oncology* Biology* Physics 89 (5), 1038-1046, 2014
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ...
The lancet oncology 17 (11), 1612-1620, 2016
Decipher genomic classifier measured on prostate biopsy predicts metastasis risk
EA Klein, Z Haddad, K Yousefi, LLC Lam, Q Wang, V Choeurng, ...
Urology 90, 148-152, 2016
Individual patient-level meta-analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease
DE Spratt, K Yousefi, S Deheshi, AE Ross, RB Den, EM Schaeffer, ...
Journal of Clinical Oncology 35 (18), 1991, 2017
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20